Link to the paper: https://www.ncbi.nlm.nih.gov/pubmed/22914710 Introduction It’s been found that the usage of allogenic blood products are independently associated with increased mortality and adverse events. In literature, it states that an accurate diagnosis of underlying hemostatic pathology is important and so having an algorithm driven hemostatic therapy is important and found to be better than clinical…